Differential gene expression profiling was carried out on primary tumour tissues and adjacent non-neoplastic tissues from patients with oesophageal squamous cell carcinoma (ESCC). RNA extracted from ESCC tissues and matched normal oesophageal epithelium of four ESCC patients was analysed using whole-genome microarrays. Bioinformatics analysis was also carried out to ascertain which genes and pathways may be important in the carcinogenesis of ESCC. A total of 570 genes were identified that differed significantly in expression: 303 genes were up-regulated and 267 genes were down-regulated in ESCC tissues compared with normal oesophageal epithelium. Gene ontology analysis showed that the primary molecular functions of these genes were related to the extracellular region, collagen and endopeptidase inhibitor activity. Pathway analysis revealed seven pathways or networks highly associated with the differential expression profile. Gene set analysis showed that the POD1_KO_UP gene set was significantly enriched, containing 15 matching genes. Thus, a large number of genes are involved in the carcinogenesis of ESCC and participate in various cell processes and pathways.
Introduction
Oesophageal squamous cell carcinoma (ESCC) is one of the most prevalent malignant diseases worldwide and, despite significant advances in multidisciplinary treatment approaches, such as surgery, chemotherapy and radiotherapy, still has one of the worst prognoses of all neoplastic diseases. 1 At present, surgical resection is the first choice for the treatment of ESCC, however most patients have advanced disease at the time of diagnosis and, in China, the 5-year survival rate is reported to be around 35%. 2 Lymph node metastasis (LNM) correlates with a poor outcome in patients with ESCC, and accurate detection JD Li, QC Feng, JS Li Gene expression profiling of oesophageal squamous cell carcinoma of LNM is an essential component of the approach to treatment. 3 In clinical practice, LNM may have already taken place even when the primary tumour is still relatively small. There is, therefore, an urgent need for molecular markers for the early detection of ESCC in order to determine the optimal choice of surgical procedure. Carcinogenesis is a complex, multistep biological process involving gene expression profile alterations. Understanding gene expression patterns and the underlying mechanisms of carcinogenesis in ESCC may help in the development of diagnostic, prognostic and therapeutic tools to improve outcome.
Microarray technology has emerged as an indispensable research tool for gene expression profiling, allowing the simultaneous analysis of thousands of transcripts within a single experiment. With regard to ESCC, a number of studies have been performed to identify genes related to carcinogenesis or metastasis. 4 -8 In particular, there have been several attempts to identify gene profiles that predict LNM in patients with ESCC. For example, Kan et al. 9 reported that molecular profiling of 60 genes may accurately predict LNM in ESCC. To our knowledge, however, there is a lack of bioinformatics analyses of these gene expression profiles. Such analyses may provide valuable insight into the genesis and metastasis of ESCC, and may also facilitate the identification of novel markers for the prediction of LNM.
In the present study differential expression profiling was performed on primary tumour tissues and adjacent nonneoplastic tissues from patients with ESCC using oligonucleotide arrays for wholegenome gene expression analysis and bioinformatics analysis to ascertain which genes and pathways may be important in the carcinogenesis of ESCC.
Patients and methods

PATIENTS AND SPECIMENS
Primary tumour tissues and adjacent nonneoplastic tissues (taken 5 cm from the tumour edge) were obtained from patients with ESCC who underwent surgical treatment at the Department of Digestive Diseases of the First Affiliated Hospital of Zhengzhou University between November 2007 and May 2008. All tissues were frozen in liquid nitrogen immediately after surgical resection. None of the patients had undergone prior chemotherapy or radiotherapy, or had any other serious diseases. Written informed consent was obtained from the patients before surgery and the study protocol was approved by the Institutional Review Board for the Use of Human Subjects at Zhengzhou University.
All ESCC tissues were diagnosed histopathologically by at least two trained pathologists. Tumours were classified for stage and grade according to the pathological tumour-node-metastasis (TNM) classification of the International Union against Cancer and the American Joint Committee on Cancer. 10
RNA EXTRACTION AND PROCESSING
Total RNA was isolated using Trizol ® reagent (Invitrogen, Carlsbad, CA, USA), according to the manufacturer's suggested procedures, and then quantified using a spectrophotometer. Amplification and labelling of complementary RNA (cRNA) with biotin were performed using the Illumina ® TotalPrep™ RNA amplification kit (Ambion, Austin, TX, USA) on an aliquot of 440 ng total RNA as input material. In vitro transcription of complementary DNA (cDNA) to cRNA was performed overnight using biotin-11-deoxyuridine triphosphate (biotin-11-dUTP) to label the cRNA product. 
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The cRNA yields were quantified with a spectrophotometer. Labelled cRNA (500 ng) was then hybridized to Human Ref6V3 BeadChip™ arrays containing 48 000 transcripts (Illumina, San Diego, CA, USA) at 55°C overnight following staining with 1 µg/ml streptavidin-Cy3™ (Amersham Biosciences, Piscataway, NJ, USA) for visualization. Gene expression analysis was performed using the Sentrix ® BeadChip™ and BeadStation system (Illumina). Quality standards for hybridization, labelling, staining, background signal and basal level of housekeeping gene expression for each chip were verified. After scanning the probe array, the resulting image was analysed using BeadStudio™ software (Illumina).
BIOINFORMATICS ANALYSIS
Raw intensity data from BeadStudio™ were exported to GeneSpring™ GX 11.0 (Agilent Technologies, Santa Clara, CA, USA) for further analysis. Paired t-test analysis was used to obtain probe sets whose fold change between ESCC tissue and normal oesophageal epithelium was ≥ 2.0 (with a Pvalue cut-off of < 0.01). Average linkage hierarchical clustering was performed and the Pearson centred distance metric was used as a measure of similarity between the gene expression patterns for each pair of samples based on log-transformed signal values across all genes. The gene ontology (GO) option of GeneSpring™ GX 11.0 was used to determine the most significant biological processes. The BioPAX pathways/networks exchange format was exported to GeneSpring™ GX 11.0 and the Find Significant Pathway tool was then used to identify the biological pathway for which there was significant enrichment in the differential expression gene list. Gene set analysis (GSA) was performed using GeneSpring™ GX 11.0, as described previously. 11
Results
PATIENTS
Primary tumour tissues and adjacent nonneoplastic tissues were obtained from four patients diagnosed with ESCC. Their clinical and pathological data are summarized in Table 1 .
GLOBAL DIFFERENCES IN GENE EXPRESSION
Using Illumina ® HumanRef6V3 BeadChip™ arrays (composed of 48 000 probe sets designed to measure human messenger RNA), the profiles of primary tumour tissues and their matched (adjacent) normal oesophageal epithelium were compared from the four patients with ESCC. After performing paired t-test analyses, 570 genes JD Li, QC Feng, JS Li Gene expression profiling of oesophageal squamous cell carcinoma (590 probe sets) whose expression differed significantly at P < 0.01 with a fold change ≥ 2 were identified. Of these, 303 genes were up-regulated and 267 genes were downregulated. Data on the 10 genes found to be most frequently up-regulated and the 10 found to be most frequently down-regulated in ESCC tumour tissue compared with adjacent normal tissue are shown in Tables 2 and 3, respectively. Genes differing in expression were represented in a volcano plot ( Fig. 1 ) and then selected for hierarchical clustering analysis. As shown in 
GENE ONTOLOGY ANALYSIS
All genes showing differential expression were analysed using the GO option of GeneSpring™ GX 11.0, yielding 17 significant GO terms (corrected P-value < 0.05). Detailed information on these GO terms is given in Table 4 . The top five GO terms were: (i) extracellular region (corrected P = 4.48 × 10 −11 ); (ii) extracellular region part (corrected P-value 6.08 × 10 −8 ); (iii) collagen (corrected P = 1.76 × 10 −5 ); (iv) extracellular matrix (corrected P = 5.56 × 10 −4 ); and (v) endopeptidase inhibitor activity (corrected P = 0.001229). These GO terms were associated with numerous genes associated with matrix metalloproteinases (MMPs) and collagen, such as MMP3, MMP9, MMP10, MMP11, MMP12, COL6A3, COL10A1, COL1A1, COL1A2, COL3A1, COL5A2 and COL5A1. Furthermore, a number of genes associated with endopeptidase inhibitor activity were also observed, including SPINK5, SPINK7, SERPINB3 and THBS1.
FIND SIGNIFICANT PATHWAY AND GSA
Using the Find Significant Pathway tool in Fold change (x-axis) is plotted against statistical significance (y-axis) for each probe set. Genes up-regulated with a fold change ≥ 2 and with P < 0.01 are depicted in red and those down-regulated with a fold change ≥ 2 and with P < 0.01 are shown in green. Grey represents genes in the array that were not found to differ significantly between ESCC tissues and adjacent normal oesophageal epithelium GeneSpring™ GX 11.0 and public pathway databases (Reactome, BioCyc and Pathway Commons), the following seven pathways or networks were found as most closely associated with the genes that exhibited significant differential expression (P < 0.05) between primary tumour tissues and adjacent normal tissues: (i) inhibition of matrix metalloproteinases (P = 0.023); (ii) signalling to extracellular signal-related kinases (P = 0.035); (iii) signalling by nerve growth factor (NGF) (P = 0.029); (iv) fibroblast growth factor signalling pathway (P = 0.003); (v) N-cadherin signalling events (P = 0.035); (vi) caspase cascade in apoptosis (P = 0.007); and (vii) integrins in angiogenesis (P = 9.24 × 10 −4 ). By GSA, the POD1_KO_UP gene set (Harvard and Massachusetts Institute of Technology Broad Institute C2 collection) was found to be significantly (P < 0.029) enriched, with 15 matching genes.
Discussion
It is well known that the pathogenesis of tumours involves a series of complicated processes including the activation of oncogenes and inactivation of tumour suppressor genes. Determining differences in gene expression between tumour and normal tissues is, therefore, essential if understanding of this process is to be improved. Along with various improved molecular biological techniques, microarrays have been widely used in detecting the gene expression profiles of various kinds 
FIGURE 2:
Cluster analysis of the probes that were increased and decreased significantly in oesophageal squamous cell carcinoma (ESCC) tissues compared with adjacent normal epithelium from four patients (P < 0.01, fold change ≥ 2). A dendrogram of the cluster correlation is shown on the right. Pseudocolours indicate differential expression (red, transcript levels greater than the median; black, transcript levels equal to median; green, transcript levels below the median) (saturation thresholds were the GeneSpring™ GX 11.00 defaults) of tumours, including ESCC. 5, 12 For example, Yamabuki et al. 13 investigated the molecular profiling of ESCC by using low-density cDNA arrays that included a limited number of genes. A novel feature of the present study is that Illumina ® HumanRef6V3 BeadChip™ arrays that contained 48 000 probe sets were used to determine differential gene expression between ESCC tissues and adjacent normal tissues. In addition, in order to reduce the effects of other factors on gene expression, patients with other serious diseases or who received pre-operative chemotherapy or radiotherapy were excluded.
Yamabuki et al. 13 identified 147 genes that were commonly up-regulated and 376 transcripts that were down-regulated in ESCC cells compared with non-cancerous oesophageal epithelial cells by using a cDNA microarray representing 32 256 genes. Moreover, Chattopadhyay et al. 7 performed gene profiling analysis with pooled tissues from 16 ESCC patients using a human 10 K cDNA chip and identified 923 genes that differed in expression between ESCC tissues and paired normal tissues. These findings indicate that a large number of genes change their expression during the occurrence and development of ESCC. To identify the gene expression profiles that are most frequently altered in ESCC, strict screening criteria (P < 0.01, fold change ≥ 2) were used in the present study, which found that 303 genes were up-regulated and 267 genes were down-regulated in ESCC tissues compared with their paired (adjacent) normal tissues. A careful literature review showed that most of the 10 most frequently up-regulated and the 10 most frequently Endopeptidase inhibitor activity P = 0.001229 8 0005578
GO Accession
Proteinaceous extracellular matrix P = 0.001229 11 0030414
Protease inhibitor activity P = 0.001229 8 0005615
Extracellular space P = 0.002185 15 0004867
Serine-type endopeptidase inhibitor activity P = 0.004339 7 0005198
Structural molecule activity P = 0.005728 13 0030574
Collagen catabolic process P = 0.009594 4 0044420
Extracellular matrix part P = 0.010408 6 0005201
Extracellular matrix structural constituent P = 0.014931 6 0008233
Peptidase activity P = 0.015324 13 0004175
Endopeptidase activity P = 0.015587 6 0004857
Enzyme inhibitor activity P = 0.044071 8 0004222
Metalloendopeptidase activity P = 0.045258 6 a Multiple testing correction. GO, gene ontology. TRAG3) , originally identified as a taxol resistance-associated gene from an ovarian carcinoma cell line, is frequently over-expressed in many human tumours, including melanoma and colorectal, breast and oesophageal tumours. 14 -17 Clinically, because many patients progress quickly to metastatic or recrudescent disease, ESCC has been recognized as an aggressive cancer and as having a very poor prognosis. MMPs are key enzymes responsible for breakdown of the extracellular matrix and thereby play a vital role in invasion and metastasis, a process that involves attachment of tumour cells to the basement membrane, degradation of local connective tissue, and penetration and migration of tumour cells through the proteolysed stroma. So far, 26 MMP genes have been identified in humans and most of them have been implicated in cancer. 18 In the present study, GO analysis was used to analyse the major biological processes and molecular functions in which these differentially expressed genes participate. Interestingly, a number of MMP genes, such as MMP3, MMP9, MMP10, MMP11 and MMP12, were observed to be associated with significant GO terms, which is consistent with previous studies in oesophageal and other aggressive types of cancer. 9, 19, 20 The altered expression of these MMP genes seems a reasonable explanation for the aggressiveness and poor prognosis of oesophageal cancer. Furthermore, by using the Find Significant Pathway tool in GeneSpring™ GX 11.0, seven pathways or networks that were closely associated with the list of differentially expressed genes were also found, demonstrating the likely involvement of these genes in carcinogenesis and the development and metastasis of various cancer types. Notably, the POD1_KO_UP gene set was significantly enriched, being shown by GSA analysis to contain 15 matching genes. 21 This result suggests that the up-regulated genes involved in POD1 gene knockout may be associated with the genesis of ESCC and warrants further exploration.
An unavoidable limitation of the present study arises from the fact that whole tissues were used for gene expression analysis. It is, therefore, possible that some of the detected changes in gene expression were associated with stromal or infiltrating inflammatory cells rather than with the tumour compartment only.
In summary, the present microarray study showed that a large number of genes are involved in the genesis of ESCC and that they participate in various cell processes and pathways. In addition, these findings contribute information that may be useful in screening for genes related to the genesis of ESCC.
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